These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 27901626)

  • 1. Experiences of Living With Opioid Dependence: An Interview Study Among Individuals Participating in Medication-Assisted Treatment.
    Melin Y; Eklund M; Lindgren BM
    Issues Ment Health Nurs; 2017 Jan; 38(1):9-17. PubMed ID: 27901626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From Resistance to Existence-Experiences of Medication-Assisted Treatment as Disclosed by People with Opioid Dependence.
    Lindgren BM; Eklund M; Melin Y; Graneheim UH
    Issues Ment Health Nurs; 2015; 36(12):963-70. PubMed ID: 26735504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical Opioid Use and Dependence among People Living with Chronic Pain: Associations Observed within the Pain and Opioids in Treatment (POINT) Cohort.
    Campbell G; Nielsen S; Larance B; Bruno R; Mattick R; Hall W; Lintzeris N; Cohen M; Smith K; Degenhardt L
    Pain Med; 2015 Sep; 16(9):1745-58. PubMed ID: 26011277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The characteristics of a cohort who tamper with prescribed and diverted opioid medications.
    Larance B; Lintzeris N; Bruno R; Peacock A; Cama E; Ali R; Kihas I; Hordern A; White N; Degenhardt L
    J Subst Abuse Treat; 2015 Nov; 58():51-61. PubMed ID: 26286818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term self-treatment with methadone or buprenorphine as a response to barriers to opioid substitution treatment: the case of Sweden.
    Richert T; Johnson B
    Harm Reduct J; 2015 Feb; 12():1. PubMed ID: 25889208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Family burden in opioid dependence syndrome in tertiary care centre.
    Shyangwa PM; Tripathi BM; Lal R
    JNMA J Nepal Med Assoc; 2008; 47(171):113-9. PubMed ID: 19079374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Borderline personality disorder features and risk for prescription opioid use disorders.
    Tragesser SL; Jones RE; Robinson RJ; Stutler A; Stewart A
    J Pers Disord; 2013 Aug; 27(4):427-41. PubMed ID: 23718741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A group therapy program for opioid-dependent adolescents and their parents.
    Pugatch M; Knight JR; McGuiness P; Sherritt L; Levy S
    Subst Abus; 2014; 35(4):435-41. PubMed ID: 25174347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agreement between definitions of pharmaceutical opioid use disorders and dependence in people taking opioids for chronic non-cancer pain (POINT): a cohort study.
    Degenhardt L; Bruno R; Lintzeris N; Hall W; Nielsen S; Larance B; Cohen M; Campbell G
    Lancet Psychiatry; 2015 Apr; 2(4):314-22. PubMed ID: 26360084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical opioid analgesic and heroin dependence: how do treatment-seeking clients differ in Australia?
    Nielsen S; Bruno R; Lintzeris N; Fischer J; Carruthers S; Stoové M
    Drug Alcohol Rev; 2011 May; 30(3):291-9. PubMed ID: 21545560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Social Support and Attachment Style on Quality of Life and Readiness to Change in a Sample of Individuals Receiving Medication-Assisted Treatment for Opioid Dependence.
    Cavaiola AA; Fulmer BA; Stout D
    Subst Abus; 2015; 36(2):183-91. PubMed ID: 25839214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-perceived problem with alcohol use among opioid substitution treatment clients.
    Islam MM; Day CA; Conigrave KM; Topp L
    Addict Behav; 2013 Apr; 38(4):2018-21. PubMed ID: 23384455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diversion of methadone and buprenorphine from opioid substitution treatment: patients who regularly sell or share their medication.
    Johnson B; Richert T
    J Addict Dis; 2015; 34(1):1-17. PubMed ID: 25496247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HIV-infected drug addicts in a clinic for infectious diseases are dissatisfied and desire more treatment].
    Tokåker PO; Spångberg L; Pehrson P
    Lakartidningen; 1991 Mar; 88(12):1069, 1071-2. PubMed ID: 2016939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experiences of patients requiring strong opioid drugs for chronic non-cancer pain: a patient-initiated study.
    Blake S; Ruel B; Seamark C; Seamark D
    Br J Gen Pract; 2007 Feb; 57(535):101-8. PubMed ID: 17263926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of opioid prescription medication dependence and detoxification on pain perceptions and self-reports.
    Miller NS; Swiney T; Barkin RL
    Am J Ther; 2006; 13(5):436-44. PubMed ID: 16988540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder.
    Fox AD; Maradiaga J; Weiss L; Sanchez J; Starrels JL; Cunningham CO
    Addict Sci Clin Pract; 2015 Jan; 10(1):2. PubMed ID: 25592182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathogenesis of psychological appearances of opioid dependence: a dualistic model].
    Sivolap IuP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(1):70-2. PubMed ID: 16457139
    [No Abstract]   [Full Text] [Related]  

  • 19. Stimulant medication for ADHD in opioid maintenance treatment.
    Abel KF; Bramness JG; Martinsen EW
    J Dual Diagn; 2014; 10(1):32-8. PubMed ID: 25392060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pain volatility and prescription opioid addiction treatment outcomes in patients with chronic pain.
    Worley MJ; Heinzerling KG; Shoptaw S; Ling W
    Exp Clin Psychopharmacol; 2015 Dec; 23(6):428-35. PubMed ID: 26302337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.